Zenrelia Tablet
Zenrelia (ilunocitinib tablets) is a veterinary medication used to treat allergic dermatitis (skin allergies) in dogs. It works by inhibiting certain enzymes involved in the inflammatory process, reducing itching, redness, and skin lesions.
Ilunocitinib, commercially available as Zenrelia, is a Janus kinase (JAK) inhibitor utilized for managing the body's response to environmental triggers. It is a prescription medication available for use in dogs, requiring professional guidance and monitoring by a licensed veterinarian. It is frequently considered in the context of allergic dermatitis for managing significant itching and inflammation.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, it manages the activity of JAK enzymes involved in signaling for itch and immune responses. Commonly observed effects include localized digestive changes such as vomiting or diarrhea and behavioral shifts. Because it manages immune signaling, your veterinarian will monitor for observational signs of sensitivity or susceptibility to infection through regular physical exams. Owners should monitor for any unusual behavioral changes and contact their veterinarian promptly with any concerns. It is typically evaluated carefully in dogs with a history of malignancy.
Yes. Zenrelia is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all legal and professional standards are met.
Veterinarians discuss Zenrelia because it blocks the specific signals in the body that cause the sensation of an "itch." This may be considered in the context of managing your dog's comfort during seasonal allergies.
Your veterinarian will recommend periodic check-ups and may suggest blood work to monitor the physiological response to the medication. This monitoring ensures the management approach remains safe for your pet.
Zenrelia is typically authorized for dogs above a specific age. Your veterinarian will determine if this management approach is appropriate for your individual pet based on their age and health status.
You should discuss your dog's complete medication history with your veterinarian. They will determine if combining Zenrelia with other anti-inflammatory management is appropriate for your pet.
